These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21334407)

  • 21. Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma.
    Nakamura I; Hatano E; Tada M; Kawabata Y; Tamagawa S; Kurimoto A; Iwama H; Toriguchi K; Sueoka H; Iida K; Yoshida M; Nishimura T; Iijima H
    Surg Today; 2021 May; 51(5):764-776. PubMed ID: 32964250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.
    Peng S; Wang Y; Peng H; Chen D; Shen S; Peng B; Chen M; Lencioni R; Kuang M
    Hepatology; 2014 Oct; 60(4):1264-77. PubMed ID: 24849467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
    Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
    BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score.
    Kawamura E; Habu D; Ohfuji S; Fukushima W; Enomoto M; Torii K; Kawabe J; Kondo K; Tamori A; Kawada N; Shiomi S
    Hepatogastroenterology; 2008; 55(82-83):582-6. PubMed ID: 18613412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic study of angiogenesis in human hepatocellular carcinoma].
    Ma J; Zhou X; Zhang T; Sun G; Meng K
    Zhonghua Bing Li Xue Za Zhi; 2000 Aug; 29(4):248-51. PubMed ID: 11866917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].
    Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
    Ng IO; Ng M; Fan ST
    Am J Gastroenterol; 1997 Aug; 92(8):1355-8. PubMed ID: 9260806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.
    Cui J; Dong BW; Liang P; Yu XL; Yu DJ
    World J Gastroenterol; 2004 May; 10(10):1533-6. PubMed ID: 15133868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression.
    Amaoka N; Osada S; Kanematsu M; Imai H; Tomita H; Tokuyama Y; Sakashita F; Nonaka K; Goshima S; Kondo H; Adachi Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2202-7. PubMed ID: 18031381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.